On Invalid Date, Paragon 28 (NYSE: FNA) reported Q1 2024 earnings per share (EPS) of -$0.18, up 63.64% year over year. Total Paragon 28 earnings for the quarter were -$15.23 million. In the same quarter last year, Paragon 28's earnings per share (EPS) was -$0.11.
As of Q2 2024, Paragon 28's earnings has grown year over year. Paragon 28's earnings in the past year totalled -$54.02 million.
What was FNA's revenue last quarter?
On Invalid Date, Paragon 28 (NYSE: FNA) reported Q1 2024 revenue of $61.08 million up 17.38% year over year. In the same quarter last year, Paragon 28's revenue was $52.04 million.
What was FNA's revenue growth in the past year?
As of Q2 2024, Paragon 28's revenue has grown 17.38% year over year. This is 6.69 percentage points higher than the US Medical Devices industry revenue growth rate of 10.69%. Paragon 28's revenue in the past year totalled $225.44 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.